124 related articles for article (PubMed ID: 18629778)
1. Parallel assessment of circulatory cell-free DNA by PCR and nucleosomes by ELISA in breast tumors.
Seefeld M; El Tarhouny S; Fan AX; Hahn S; Holzgreve W; Zhong XY
Int J Biol Markers; 2008; 23(2):69-73. PubMed ID: 18629778
[TBL] [Abstract][Full Text] [Related]
2. Levels of circulating cell-free serum DNA in benign and malignant breast lesions.
Zanetti-Dällenbach RA; Schmid S; Wight E; Holzgreve W; Ladewing A; Hahn S; Zhong XY
Int J Biol Markers; 2007; 22(2):95-9. PubMed ID: 17549664
[TBL] [Abstract][Full Text] [Related]
3. Comparison of serum VEGF and its soluble receptor sVEGFR1 with serum cell-free DNA in patients with breast tumor.
El Tarhouny S; Seefeld M; Fan AX; Hahn S; Holzgreve W; Zhong XY
Cytokine; 2008 Oct; 44(1):65-9. PubMed ID: 18691902
[TBL] [Abstract][Full Text] [Related]
4. Positive correlation of cell-free DNA in plasma/serum in patients with malignant and benign breast disease.
Zanetti-Dällenbach R; Wight E; Fan AX; Lapaire O; Hahn S; Holzgreve W; Zhong XY
Anticancer Res; 2008; 28(2A):921-5. PubMed ID: 18507037
[TBL] [Abstract][Full Text] [Related]
5. Apoptosis-related deregulation of proteolytic activities and high serum levels of circulating nucleosomes and DNA in blood correlate with breast cancer progression.
Roth C; Pantel K; Müller V; Rack B; Kasimir-Bauer S; Janni W; Schwarzenbach H
BMC Cancer; 2011 Jan; 11():4. PubMed ID: 21211028
[TBL] [Abstract][Full Text] [Related]
6. HER-2 gene amplification, serum nucleosomes, CEA and CA15.3 tumor markers in breast cancer patients.
Zeiwar MM; Zaki SM; Mohammad LA; Zidan AA; El Nagar MR
Egypt J Immunol; 2007; 14(2):29-41. PubMed ID: 20306655
[TBL] [Abstract][Full Text] [Related]
7. Elevated level of cell-free plasma DNA is associated with breast cancer.
Zhong XY; Ladewig A; Schmid S; Wight E; Hahn S; Holzgreve W
Arch Gynecol Obstet; 2007 Oct; 276(4):327-31. PubMed ID: 17431649
[TBL] [Abstract][Full Text] [Related]
8. MYC quantitation in cell-free plasma DNA by real-time PCR for gastric cancer diagnosis.
Park KU; Lee HE; Park DJ; Jung EJ; Song J; Kim HH; Choe G; Kim WH; Lee HS
Clin Chem Lab Med; 2009; 47(5):530-6. PubMed ID: 19302034
[TBL] [Abstract][Full Text] [Related]
9. Assessment of cell-free DNA with microvascular complication of type II diabetes mellitus, using PCR and ELISA.
El Tarhouny SA; Hadhoud KM; Ebrahem MM; Al Azizi NM
Nucleosides Nucleotides Nucleic Acids; 2010 Mar; 29(3):228-36. PubMed ID: 20408053
[TBL] [Abstract][Full Text] [Related]
10. Increased concentrations of antibody-bound circulatory cell-free DNA in rheumatoid arthritis.
Zhong XY; von Mühlenen I; Li Y; Kang A; Gupta AK; Tyndall A; Holzgreve W; Hahn S; Hasler P
Clin Chem; 2007 Sep; 53(9):1609-14. PubMed ID: 17712000
[TBL] [Abstract][Full Text] [Related]
11. Reliability and discriminant validity of HER2 gene quantification and chromosome 17 aneusomy analysis by real-time PCR in primary breast cancer.
Lamy PJ; Nanni I; Fina F; Bibeau F; Romain S; Dussert C; Penault Llorca F; Grenier J; Ouafik LH; Martin PM
Int J Biol Markers; 2006; 21(1):20-9. PubMed ID: 16711510
[TBL] [Abstract][Full Text] [Related]
12. Levels of plasma circulating cell free nuclear and mitochondrial DNA as potential biomarkers for breast tumors.
Kohler C; Radpour R; Barekati Z; Asadollahi R; Bitzer J; Wight E; Bürki N; Diesch C; Holzgreve W; Zhong XY
Mol Cancer; 2009 Nov; 8():105. PubMed ID: 19922604
[TBL] [Abstract][Full Text] [Related]
13. Glyceraldehyde-3-phosphate dehydrogenase gene expression in human breast cancer.
Révillion F; Pawlowski V; Hornez L; Peyrat JP
Eur J Cancer; 2000 May; 36(8):1038-42. PubMed ID: 10885609
[TBL] [Abstract][Full Text] [Related]
14. Quantitative determination of telomerase activity in breast cancer and benign breast diseases.
Simícková M; Nekulová M; Pecen L; Cernoch M; Vagundová M; Pacovský Z
Neoplasma; 2001; 48(4):267-73. PubMed ID: 11712677
[TBL] [Abstract][Full Text] [Related]
15. Circulatory nucleosome levels are significantly increased in early and late-onset preeclampsia.
Zhong XY; Gebhardt S; Hillermann R; Tofa KC; Holzgreve W; Hahn S
Prenat Diagn; 2005 Aug; 25(8):700-3. PubMed ID: 16050002
[TBL] [Abstract][Full Text] [Related]
16. Mammaglobin as a novel breast cancer biomarker: multigene reverse transcription-PCR assay and sandwich ELISA.
Zehentner BK; Persing DH; Deme A; Toure P; Hawes SE; Brooks L; Feng Q; Hayes DC; Critichlow CW; Houghton RL; Kiviat NB
Clin Chem; 2004 Nov; 50(11):2069-76. PubMed ID: 15375015
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic Value of Serum Concentration and Integrity of Circulating Cell-Free DNA in Breast Cancer: A Comparative Study With CEA and CA15-3.
Tang Z; Li L; Shen L; Shen X; Ju S; Cong H
Lab Med; 2018 Oct; 49(4):323-328. PubMed ID: 29701836
[TBL] [Abstract][Full Text] [Related]
18. Cell-free DNA in serum and plasma: comparison of ELISA and quantitative PCR.
Holdenrieder S; Stieber P; Chan LY; Geiger S; Kremer A; Nagel D; Lo YM
Clin Chem; 2005 Aug; 51(8):1544-6. PubMed ID: 16040855
[No Abstract] [Full Text] [Related]
19. Quantification of free circulating tumor DNA as a diagnostic marker for breast cancer.
Catarino R; Ferreira MM; Rodrigues H; Coelho A; Nogal A; Sousa A; Medeiros R
DNA Cell Biol; 2008 Aug; 27(8):415-21. PubMed ID: 18694299
[TBL] [Abstract][Full Text] [Related]
20. Comparative evaluation of plasma levels and diagnostic values of macrophage-colony stimulating factor in patients with breast cancer and benign tumors.
Ławicki S; Czygier M; Bedkowska E; Wojtukiewicz M; Szmitkowski M
Pol Arch Med Wewn; 2008 Sep; 118(9):464-9. PubMed ID: 18846980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
